SRP-9004
SRP-9004-102
Phase 1 small_molecule terminated
Quick answer
SRP-9004 for Limb Girdle Muscular Dystrophy is a Phase 1 program (small_molecule) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Limb Girdle Muscular Dystrophy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated